Axonal degeneration as a therapeutic target in the CNS
Open Access
- 6 March 2012
- journal article
- review article
- Published by Springer Nature in Cell and tissue research
- Vol. 349 (1) , 289-311
Abstract
Degeneration of the axon is an important step in the pathomechanism of traumatic, inflammatory and degenerative neurological diseases. Increasing evidence suggests that axonal degeneration occurs early in the course of these diseases and therefore represents a promising target for future therapeutic strategies. We review the evidence for axonal destruction from pathological findings and animal models with particular emphasis on neurodegenerative and neurotraumatic disorders. We discuss the basic morphological and temporal modalities of axonal degeneration (acute, chronic and focal axonal degeneration and Wallerian degeneration). Based on the mechanistic concepts, we then delineate in detail the major molecular mechanisms that underlie the degenerative cascade, such as calcium influx, axonal transport, protein aggregation and autophagy. We finally concentrate on putative therapeutic targets based on the mechanistic prerequisites.Keywords
This publication has 225 references indexed in Scilit:
- Nmnat exerts neuroprotective effects in dendrites and axonsMolecular and Cellular Neuroscience, 2011
- Amyloid beta impairs mitochondrial anterograde transport and degenerates synapses in Alzheimer's disease neuronsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2011
- Axonal inclusions in spinocerebellar ataxia type 3Acta Neuropathologica, 2010
- L‐type calcium channel blockers and Parkinson disease in DenmarkAnnals of Neurology, 2010
- Mechanisms of axonal injury: internodal nanocomplexes and calcium deregulationTrends in Molecular Medicine, 2010
- Mitochondrial dysfunction in amyotrophic lateral sclerosisBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2010
- Mechanical membrane injury induces axonal beading through localized activation of calpainExperimental Neurology, 2009
- Calpain-Mediated Signaling Mechanisms in Neuronal Injury and NeurodegenerationMolecular Neurobiology, 2008
- In vivo axonal transport rates decrease in a mouse model of Alzheimer's diseaseNeuroImage, 2007
- A novel endogenous erythropoietin mediated pathway prevents axonal degenerationAnnals of Neurology, 2004